Share on StockTwits

TrovaGene (NASDAQ:TROV) CFO Steve Zaniboni purchased 6,329 shares of the stock in a transaction dated Monday, June 9th. The shares were purchased at an average cost of $3.95 per share, for a total transaction of $24,999.55. Following the transaction, the chief financial officer now directly owns 6,329 shares of the company’s stock, valued at approximately $25,000. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this link.

TrovaGene (NASDAQ:TROV) traded down 0.51% during mid-day trading on Tuesday, hitting $3.88. The stock had a trading volume of 40,598 shares. TrovaGene has a one year low of $3.38 and a one year high of $10.27. The stock’s 50-day moving average is $4.44 and its 200-day moving average is $5.44. The company’s market cap is $73.3 million.

TrovaGene (NASDAQ:TROV) last posted its quarterly earnings results on Monday, May 12th. The company reported ($0.17) earnings per share for the quarter, beating the analysts’ consensus estimate of ($0.23) by $0.06. Analysts expect that TrovaGene will post $-0.78 EPS for the current fiscal year.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.